WKN DE: A2PHG6 / ISIN: CA59935V1076

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Milestone Pharmaceuticals Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Milestone Pharmaceuticals Inc Registered Shs

Weitere Meldungen

06:00		Europe’s green steel ambitions falter as energy costs take toll
06:00		Top US companies walk fine line on climate amid competing pressures
06:00		Build or buy? Legal teams split on how to exploit AI
06:00		Accounting sector prepares for more IPOs after private equity binge
06:00		Business school teaching case study: should I stay, or should I go? UBS’s Net-Zero Banking Alliance dilemma
06:00		Accounting sector prepares for more IPOs after private equity binge
06:00		Why markets are unfazed by the Middle East conflict
06:00		Why markets are unfazed by the Middle East conflict
05:27		Trump Family-Backed World Liberty Financial Plans To Launch A New App That Will Make It Easy For Lay Investors To Use Crypto
05:05		Mark Zuckerberg's Meta Beats Lawsuit Over AI Training On Books, Judge Finds 'No Meaningful Evidence On Market Dilution'
05:04		Bayern und Wien bewerben sich als Standorte für EU-geförderte KI-Gigafabriken
04:53		Bitcoin Tops This Key Level As Institutions Pile On, Ethereum, Dogecoin Rangebound: Analyst Says Buying BTC Now Is Like Buying It For $20,000 In 2020
04:12		Trump Says Democrats Have 'Crossed The Line' With Zohran Mamdani — Bernie Sanders, Elizabeth Warren Back New York Mayoral Candidate's 'Grassroots' Support
04:06		Nvidia, Micron Technology, Super Micro Computer, BP And Tesla: Why These 5 Stocks Are On Investors' Radars Today
03:38		Michael Novogratz's Galaxy And Invesco File To Launch Solana ETF: What You Should Know About QSOL
03:32		Amazon MGM Studios names Denis Villeneuve as next James Bond director
03:31		Civmec to acquire ship manufacturer Luerssen Australia for A$20 million
03:31		Civmec set to acquire ship manufacturer Luerssen Australia for A$20 million
03:23		Cathie Wood Doubles Down On Shopify, Buys The Dip — Dumps $4.6 Million Worth Of Robinhood Stock At Peak
03:16		SGS bond demand to stay high as safe havens sought amid tariff risks, Middle East tensions: RHB
03:07		Ecuador's most-wanted gang leader Fito arrested — president
03:00		CapitaLand India Trust prices S$100 million perpetual securities at 4.4%
03:00		Bumble to lay off 30% of global workforce as dating apps struggle
03:00		Meta Platforms' Reality Labs Division Recently Hit a Milestone, and It's Not a Good One
02:53		Jeff Bezos' First Marriage Ended In A $38 Billion Divorce — Now, As The Amazon Founder Plans To Marry Lauren Sanchez, He's Reportedly Ring-Fencing His $233 Billion Fortune
02:46		Foxconn nears deal to supply electric buses to Mitsubishi Fuso: report
02:46		Microsoft and OpenAI dueling over artificial general intelligence: report
02:41		Stocks to watch: SIA, Sembcorp, Keppel, Cordlife, CapitaLand India Trust, Civmec, ASL Marine
02:30		100,000 Mattresses Sold on Amazon Are Being Recalled Due to Fire Risk. Here’s What You Should Know
01:47		RFK Jr. Wants All Americans to Use Wearables to Track Their Health: What That Means
01:44		Some Republicans Join Democrats in Unease Over White House Budget Cuts
01:33		China’s Xiaomi to launch first SUV as shares near record high
01:29		Partial offer for Cordlife lapses with Thai-listed Medeze obtaining less than 1% stake
01:10		Meta wins artificial intelligence copyright case in blow to authors
01:02		No phone signal on your train? There may be a fix - by 2028
01:02		Here's How Much You Would Have Made Owning The Hartford Insurance Gr Stock In The Last 5 Years
01:01		Nearly ‘one child in every classroom’ is typically born using IVF in UK
01:00		Assisted living in Singapore: Companies face steep costs, but innovation is still possible
00:54		3 Soaring Stocks I'd Buy Now With No Hesitation
00:45		Here's How Much $1000 Invested In Applied Industrial Techs 5 Years Ago Would Be Worth Today
00:45		Why Nektar Therapeutics Stock Was Red-Hot Today
00:45		Better Dividend Stock: W.P. Carey vs. Annaly Capital Management
00:43		Micron forecasts revenue above estimates on AI-driven memory chip demand
00:42		Bernie Sanders Shares First Thing He Would Do As President — And It Could Be A Jab At Elon Musk
00:36		2 No-Brainer High-Yield Stocks to Buy With $500 Right Now
00:30		Here's How Much $100 Invested In Green Brick Partners 5 Years Ago Would Be Worth Today
00:29		Tech lobby group urges EU leaders to pause AI Act
00:27		Prediction: Amazon Stock Will Beat the Market. Here's Why.
00:17		Europe: Shares sag as investors weigh Iran-Israel ceasefire
00:16		Baseball superstar Fernando Tatis Jr. is a cautionary tale for young talent who sign away rights to millions

Zurück | 1 | 2 | 3 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: TransCanada TC Energy Corporation Cum Red 1st TC Energy Corporation Cum Red Rate Reset 1st Betsson AB Registered b Fineland Real Estate Services Group

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	26.06.2025 12:38
Kaufwert:	EUR
	Hinzufügen Speichern

Milestone Pharmaceuticals Aktie

WKN DE: A2PHG6 / ISIN: CA59935V1076

Milestone Pharmaceuticals Times and Sales (NAS)

Times and Sales

Analysen zu Milestone Pharmaceuticals Inc Registered Shs

Weitere Meldungen